financetom
Business
financetom
/
Business
/
Fin Tech Firm Dave Faces Legal Action Over Alleged Hidden Fees, Misleading Advertising
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fin Tech Firm Dave Faces Legal Action Over Alleged Hidden Fees, Misleading Advertising
Dec 31, 2024 5:45 AM

On Monday, the Department of Justice (DOJ) and the Federal Trade Commission (FTC) filed a civil enforcement action against financial technology company Dave Inc ( DAVE ) and its CEO, Jason Wilk, alleging violations of consumer protection laws.

The lawsuit claims the company engaged in deceptive practices, including hidden fees, misleading advertising, and unclear cancellation mechanisms for recurring charges.

Also Read: Financial Crime Weekly: Alleged Snowflake Hacker Arrested, Banned China Chip Shipments, Payday Advance Company Sued

Dave ( DAVE ), which offers short-term cash advances through its app, is accused of falsely marketing its services. According to the complaint, the company rarely provides the advertised "up to $500" cash advances and imposes undisclosed "express fees" for instant access to funds.

The lawsuit also alleges that Dave ( DAVE ) misrepresents how tips from users are used, claiming they fund meals for children when the company retains most tips.

The FTC and DOJ also argue that Dave's ( DAVE ) app enrolls users in recurring monthly memberships without adequately disclosing terms or offering a straightforward way to cancel.

The legal action seeks financial penalties and a permanent injunction against future violations.

The company has reacted in a statement, calling the allegations baseless and asserting that it has consistently complied with the law.

"We believe the amended complaint is an example of government overreach and includes numerous inaccuracies," the company stated.

Dave ( DAVE ) emphasized its commitment to compliance and transparency, pointing out that other regulatory agencies have previously reviewed its business model without taking action.

The company highlighted recent changes to its fee structure, eliminating optional tips and express fees for its ExtraCash product.

These changes, implemented in December 2024, aim to simplify the pricing model and enhance customer satisfaction.

According to the company, all new members have been onboarded under the revised structure, and the transition for existing users is underway. Full implementation is expected by early 2025.

Price Action: At last check on Tuesday, DAVE ( DAVE ) stock was down 9.85% to $85.16 during the premarket session.

Read Next:

Netflix's NFL Push Signals Shift In Sports Streaming Landscape, Analyst Says

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eupraxia Pharmaceuticals Seeking C$30 Million in an Overnight Marketed Share Offering
Eupraxia Pharmaceuticals Seeking C$30 Million in an Overnight Marketed Share Offering
Mar 11, 2024
04:15 PM EDT, 03/11/2024 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRXF ) on Monday said it will seek about C$30 million in an overnight marketed share offering. The biotechnology company said the size of the offering and the price of the shares will be determined when it signs an agreement with the issue's underwriter. It also expects to offer a...
Siteone Landscape Supply Insider Sold Shares Worth $540,000, According to a Recent SEC Filing
Siteone Landscape Supply Insider Sold Shares Worth $540,000, According to a Recent SEC Filing
Mar 11, 2024
04:13 PM EDT, 03/11/2024 (MT Newswires) -- John T Guthrie, Executive Vice President, CFO and Assistant Secretary, on March 08, 2024, sold 3,000 shares in Siteone Landscape Supply ( SITE ) for $540,000. Following the Form 4 filing with the SEC, Guthrie has control over a total of 15,467 shares of the company, with 15,467 shares held directly. SEC Filing:...
Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study
Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study
Mar 11, 2024
March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD ) said on Monday its experimental drug to treat negative symptoms of schizophrenia failed to meet the main goal in a late-stage study. (Reporting by Mariam Sunny in Bengaluru) ...
US transport chief expects Boeing to cooperate with DOJ, NTSB in 737 MAX probes
US transport chief expects Boeing to cooperate with DOJ, NTSB in 737 MAX probes
Mar 11, 2024
WASHINGTON (Reuters) - U.S. Transportation Secretary Pete Buttigieg said Monday he expects Boeing to cooperate in investigations by the Justice Department and National Transportation Safety Board into the Alaska Airlines 737 MAX 9 mid-air emergency on Jan. 5. We respect the independence of DOJ and NTSB doing their own work, but we're not neutral on the question of whether Boeing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved